GERMANY : German biotechnology company BioNTech is planning to produce two billion doses of COVID-19 vaccine in 2021 because of the increase in global demand, the company has said in a statement.
“In order to respond to an increased global demand, we plan to manufacture two billion doses of our COVID-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50 per cent,” the company said in a press release.
“We are on track to scale-up our manufacturing capacities,” the statement said.
Read More
- UAE residents receive missile alert as air defences respond to threat
- Massive fuel depot fire in Iraq injures around 30, burns 3 million litres of gasoline
- Pakistan Supreme Court orders former Prime Minister Imran Khan to be moved to the hospital over health concerns
- Wildfire crisis deepens across Europe as France launches €12mn aid plan
- Indians in Qatar can now send funds directly to UPI-enabled bank accounts in India through Qatar Post outlets
The company, which developed the vaccine with US-based pharma Pfizer, said the modification of production processes at Pfizer’s facility in Puurs, Belgium, had been successfully completed.
“The modification of production processes at Pfizer’s facility in Puurs, Belgium, has been successfully completed. Now, we are back to the original schedule of vaccine dose deliveries to the European Union,” it said.
According to Johns Hopkins University, 103,409,402 Covid-19 cases have been recorded globally with over 2,237,973 deaths. (ANI)
